Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management | China | 2016 | Market Analysis

The Chinese market for CRM devices will experience robust growth through 2024, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRM devices in China across a 10-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – China
The diagnostic imaging system market in China will see moderate growth in the overall diagnostic imaging space through 2034, driven by favorable demographic trends and the accelerating adoption of…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe (Supplemental)
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…